Washington Trust Advisors, Inc. Catalent, Inc. Transaction History

Washington Trust Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 14, 2022	SELL	$72.36 - $113.1 $1,230 - $1,922	-17 Reduced 4.1%	398 $29,000
Q2 2022 Jul 25, 2022	BUY	$87.2 - $114.05 $4,360 - $5,702	50 Added 13.7%	415 $45,000
Q1 2022 May 05, 2022	SELL	$94.19 - $124.49 $5,368 - $7,095	-57 Reduced 13.51%	365 $40,000
Q4 2021 Feb 11, 2022	BUY	$119.57 - $139.07 $50,458 - $58,687	422 New	422 $54,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Washington Trust Advisors, Inc. with notifications on news.